Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,545 | 74,651 | 63,289 | 51,657 | 132,164 |
| Receivables | N/A | N/A | N/A | 172 | 111 |
| TOTAL | $86,054 | $83,846 | $72,269 | $58,318 | $142,457 |
| Non-Current Assets | |||||
| PPE Net | 2,020 | 1,492 | 1,237 | 1,210 | 1,241 |
| Intangibles | 14,000 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 6,813 | 6,119 | 4,631 | 3,767 | 3,853 |
| TOTAL | $22,833 | $7,611 | $5,868 | $4,977 | $5,094 |
| Total Assets | $108,887 | $91,457 | $78,137 | $63,295 | $147,551 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 43,760 |
| Accounts payable and accrued liabilities | 3,509 | 493 | 130 | 1,589 | 2,731 |
| Accrued Expenses | 35,113 | 23,747 | 23,098 | 21,756 | 14,701 |
| Other current liabilities | 1,294 | 4,107 | 6,921 | 7,235 | 7 |
| TOTAL | $40,436 | $28,844 | $30,571 | $30,931 | $61,534 |
| Non-Current Liabilities | |||||
| Long Term Debt | 209,285 | 171,278 | 128,270 | 87,252 | 87,287 |
| Other Non-Current Liabilities | 4,783 | 4,385 | 4,232 | 3,118 | 3,179 |
| TOTAL | $214,068 | $175,663 | $132,502 | $90,370 | $90,466 |
| Total Liabilities | $254,504 | $204,507 | $163,073 | $121,301 | $152,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,743 | 31,660 | 31,182 | 30,799 | 30,520 |
| Common Shares | 0 | 2 | 0 | 0 | 0 |
| Retained earnings | -434,723 | -387,926 | -352,770 | -322,276 | -271,016 |
| Other shareholders' equity | -24 | 551 | 495 | 452 | 394 |
| TOTAL | $-145,617 | $-113,050 | $-84,936 | $-58,006 | $-4,449 |
| Total Liabilities And Equity | $108,887 | $91,457 | $78,137 | $63,295 | $147,551 |